BETA-ADRENERGIC REGULATION OF A MYOCARDIAL ACTIN GENE
心肌肌动蛋白基因的β-肾上腺素能调节
基本信息
- 批准号:2423722
- 负责人:
- 金额:$ 21.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1994
- 资助国家:美国
- 起止时间:1994-01-01 至 1998-12-31
- 项目状态:已结题
- 来源:
- 关键词:DNA binding protein actins beta adrenergic agent biological signal transduction cyclic AMP gel mobility shift assay gene expression genetic library genetic promoter element genetic transcription heart cell heart pharmacology hormone regulation /control mechanism messenger RNA neoplastic cell northern blottings nuclear runoff assay posttranscriptional RNA processing protein kinase A transfection ventricular hypertrophy
项目摘要
Beta-adrenergic agonists are strongly implicated in myocardial hypertrophy
in vivo, and beta-adrenergic and cyclic AMP (cAMP)-dependent mechanisms
are a frequent target of drugs used in ischemic cardiovascular disease and
heart failure. However, the mechanisms transducing beta-adrenoceptor-
mediated myocardial cell growth and gene expression are poorly understood.
With few exceptions, beta-adrenergic effects in the heart have been
thought to be mediated via modulation of cAMP. We have recently identified
a novel pathway for beta-adrenergic gene regulation in cardiac myocytes
that appears to be coupled to the storage or flux of calcium from
physically or biochemically defined compartments and is independent of
cAMP and cAMP-dependent protein kinase. The skeletal alpha-actin (sACT)
gene, encoding a developmentally regulated actin-actin isoform, is
selectively regulated by this pathway during beta-adrenoceptor-mediated
hypertrophy. In order to identify essential components of this signal
transduction mechanism, we propose to identify pharmacologic mechanisms
for beta-adrenergic regulation of the sACT gene and to examine
interactions between the sACT promoter and DNA-binding transcriptional
activating factors that may be required for beta-adrenergic induction.
Experiments described in part (1) will evaluate the role of beta-
adrenergic, protein kinase A-independent, and calcium-dependent mechanisms
in transcriptional and posttranscriptional regulation of the sACT gene,
employing nuclear run-on and messenger RNA half-life assays. Because we
have determined that transcriptional activating factors Fos and Jun (AP-1)
positively regulates sACT in cardiac myocytes, we will determine the
effects of protein kinase A-dependent, and calcium-dependent mechanisms on
expression of c-fos, c-jun, and related genes as well as on AP-1 binding
activity and immunoreactivity. Pl9 teratocarcinoma cells will be stably
transfected with an sACT/lacZ chimeric gene containing full-length
promoter sequences, most coding sequences and 3' flanking sequences in
order to create a cell line in which the signal-mediated regulation of
this gene can be studied directly. In part (2), beta-adrenergic and AP- 1-
responsive bases in the proximal sACT promoter will be determined by a
combination of in situ mutagenesis, gel mobility retardation assay, and
methylation interference. Cardiac myocyte nuclear proteins will be
evaluated for interaction with the sACT promoter, and a potential
interaction between serum response factor and AP-1 on this promoter will
be assessed. Finally, lambda-gt11 cardiac myocyte cDNA expression
libraries will be constructed and screened with relevant oligonucleotide
sequences from the sACT promoter.
β-肾上腺素能激动剂与心肌肥大有关
体内,β-肾上腺素能和环状AMP(CAMP)依赖性机制
是缺血性心血管疾病和
心脏衰竭。但是,转导β-肾上腺素受体的机制 -
介导的心肌细胞生长和基因表达知之甚少。
除少数例外,心脏中的β-肾上腺素能作用是
被认为是通过训练营的调节而介导的。我们最近确定了
心肌细胞中β-肾上腺素能基因调节的新途径
似乎与从
物理或生化定义的隔室,独立于
营地和cAMP依赖性蛋白激酶。骨骼α-肌动蛋白(SACT)
基因编码开发调节的肌动蛋白 - 肌动蛋白,IS
在β-肾上腺肾上腺介导的期间由该途径有选择性地调节
肥大。为了识别此信号的基本组件
转导机制,我们建议识别药理机制
用于β-肾上腺素能调节,并检查
SACT启动子与DNA结合转录之间的相互作用
β-肾上腺素能诱导可能需要的激活因子。
第(1)部分中描述的实验将评估β-
肾上腺素,蛋白激酶A非依赖性和钙依赖性机制
在SACT基因的转录和转录后调节中
采用核跑步和Messenger RNA半衰期测定法。因为我们
已经确定转录激活因子FOS和JUN(AP-1)
积极调节心肌细胞中的sact,我们将确定
蛋白激酶A依赖性和钙依赖性机制对
C-FOS,C-JUN和相关基因以及AP-1结合的表达
活性和免疫反应性。 PL9畸胎瘤细胞将稳定
用含有全长的sact/lacz嵌合基因转染
启动子序列,大多数编码序列和3'侧翼序列
为了创建一个单元线,信号介导的调节
该基因可以直接研究。在第(2)部分中,β-肾上腺素能和AP-1-
近端SACT启动子中的响应基础将由A确定
原位诱变,凝胶迁移迟缓测定和
甲基化干扰。心肌细胞核蛋白将是
评估与SATS启动子的相互作用,并且潜力
该启动子上血清反应因子与AP-1之间的相互作用将
被评估。最后,lambda-gt11心肌细胞cDNA表达
图书馆将通过相关的寡核苷酸构建和筛选
SACT启动子的序列。
项目成果
期刊论文数量(9)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Modulation of cytokine-induced cardiac myocyte apoptosis by nitric oxide, Bak, and Bcl-x.
- DOI:10.1161/01.res.84.1.21
- 发表时间:1999-01
- 期刊:
- 影响因子:20.1
- 作者:Douglas J. Ing;Jie Zang;Victor J. Dzau;Keith A. Webster;N. Bishopric
- 通讯作者:Douglas J. Ing;Jie Zang;Victor J. Dzau;Keith A. Webster;N. Bishopric
Fusigenic liposome-mediated DNA transfer into cardiac myocytes.
融合脂质体介导的 DNA 转移到心肌细胞中。
- DOI:10.1006/jmcc.1996.0130
- 发表时间:1996
- 期刊:
- 影响因子:0
- 作者:Ellison,KE;Bishopric,NH;Webster,KA;Morishita,R;Gibbons,GH;Kaneda,Y;Sato,B;Dzau,VJ
- 通讯作者:Dzau,VJ
Regulated expression of a foreign gene targeted to the ischaemic myocardium.
针对缺血心肌的外源基因的调节表达。
- DOI:10.1016/s0008-6363(97)00158-2
- 发表时间:1997
- 期刊:
- 影响因子:10.8
- 作者:Prentice,H;Bishopric,NH;Hicks,MN;Discher,DJ;Wu,X;Wylie,AA;Webster,KA
- 通讯作者:Webster,KA
Hypoxia-activated apoptosis of cardiac myocytes requires reoxygenation or a pH shift and is independent of p53.
- DOI:10.1172/jci5871
- 发表时间:1999-08
- 期刊:
- 影响因子:0
- 作者:K. Webster;D. J. Discher;Shari Kaiser;O. Hernandez;B. Sato;N. Bishopric
- 通讯作者:K. Webster;D. J. Discher;Shari Kaiser;O. Hernandez;B. Sato;N. Bishopric
Cardioprotection in an in vitro model of hypoxic preconditioning.
- DOI:10.1016/s0022-2828(08)80041-7
- 发表时间:1995
- 期刊:
- 影响因子:5
- 作者:K. Webster;D. J. Discher;N. Bishopric;N. Bishopric
- 通讯作者:K. Webster;D. J. Discher;N. Bishopric;N. Bishopric
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Nanette Hahr Bishopric其他文献
Nanette Hahr Bishopric的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Nanette Hahr Bishopric', 18)}}的其他基金
相似海外基金
BETA 2 AGONIST RESTORATION OF MUSCLE MASS IN AGED RATS
Beta 2 激动剂恢复老年大鼠的肌肉质量
- 批准号:
2393286 - 财政年份:1997
- 资助金额:
$ 21.7万 - 项目类别:
BETA-ADRENERGIC REGULATION OF A MYOCARDIAL ACTIN GENE
心肌肌动蛋白基因的β-肾上腺素能调节
- 批准号:
2225932 - 财政年份:1994
- 资助金额:
$ 21.7万 - 项目类别: